Time-dependent multivariable analysis on the relative risk of major thrombosis in ECLAP study (N = 1638)9
| White blood cell count, ×109/L . | Hazard ratio (95% CI)* . | P . |
|---|---|---|
| ≤ 10 (n = 990) | 1 (reference) | |
| 10.1-15 (n = 365) | 1.06 (0.7-1.6) | .8 |
| > 15 (n = 241) | 1.71 (1.1-2.6) | .02 |
| White blood cell count, ×109/L . | Hazard ratio (95% CI)* . | P . |
|---|---|---|
| ≤ 10 (n = 990) | 1 (reference) | |
| 10.1-15 (n = 365) | 1.06 (0.7-1.6) | .8 |
| > 15 (n = 241) | 1.71 (1.1-2.6) | .02 |
Model adjusted for: age, sex, time from PV diagnosis to recruitment, thrombotic or hemorrhagic events prior to recruitment, smoking, history of diabetes, hypertension, claudicatio intermittens, erythromelalgia, splenomegaly, circulating immature cells, leukocyte count, total blood cholesterol, phlebotomy use, interferon use, hydroxyurea use, antiplatelet use, anticoagulant use, 32P use, busulfan use, chlorambucil use, and pipobroman use.